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Abstract
Introduction: Rheumatoid arthritis is an autoimmune arthritis characterized by joint destruction. Anti-citrullinated
protein antibodies are pathologic in rheumatoid arthritis, but the role of the citrullinated proteins themselves is
much less clear. Citrullination is the conversion of the arginine residues of a protein to citrulline. In the inflamed
rheumatoid joint there is increased protein citrullination. Several proteins are citrullinated in rheumatoid arthritis,
including collagen type II, fibrinogen, and fibronectin. Fibronectin is thought to mediate the adhesion of joint-
invading synovial fibroblasts to the rheumatoid cartilage in addition to regulating other synovial fibroblast
functions. However, the effect of citrullinated fibronectin on synovial fibroblasts is unknown.
Methods: To investigate the effect of citrullinated fibronectin on synovial fibroblast behavior, we cultured normal
murine, arthritic murine, and human rheumatoid synovial fibroblasts. We then compared several synovial fibroblast
functions in the presence of fibronectin versus citrullinated fibronectin. We assessed adhesion with time-lapse
microscopy, migration with transwell assays, focal adhesion kinase and paxillin phosphorylation by western blot,
and focal matrix degradation by fluorescent gelatin degradation.
Results: Normal synovial fibroblasts have impaired adhesion, spreading, migration, and integrin-mediated
phosphorylation of focal adhesion kinase and paxillin on citrullinated fibronectin. Murine arthritic and human
rheumatoid synovial fibroblasts also have impaired adhesion and spreading on citrullinated fibronectin, but focal
matrix degradation is unaffected by citrullinated fibronectin.
Conclusion: Citrullination of fibronectin alters synovial fibroblast behavior and may affect how these cells adhere
to and invade the joint and travel through the bloodstream. This work suggests an important role for the
interaction of synovial fibroblasts with citrullinated matrix in the pathophysiology of rheumatoid arthritis.
Introduction
Rheumatoid arthritis is a chronic, debilitating arthritis
characterized by painful joint inflammation and destruc-
tive erosions. Rheumatoid arthritis has long been known
to be an inflammatory arthritis, but only recently has it
been shown to be a true autoimmune disease with an
immune response generated against self-antigens. The key
to this finding was the identification of anti-citrullinated
protein antibodies (ACPAs), which contribute to arthritis
by forming immune complexes that are deposited in the
joint [1] and by activating complement [2]. ACPAs are
specific for rheumatoid arthritis and predict severe, erosive
arthritis [3].
Despite the rapidly increasing volume of information
about ACPAs, the role of the citrullinated proteins them-
selves is less clear. Citrullination is the conversion of a
protein’s arginine residues to citrulline, resulting in a loss
of charge and often abnormal protein conformation and
function. Citrullination is catalyzed by a family of
enzymes called peptidyl arginine deiminases (PADs). Pro-
tein citrullination in the rheumatoid joint is increased [4]
and PAD4 and PAD2 are upregulated in rheumatoid
synovium [5,6] and synovial fluid [4]. Inflammation
appears to play a role in the level of citrullination since
local administration of glucocorticoids reduces citrullina-
tion in the rheumatoid joint [7]. Despite the specificity of
ACPAs to rheumatoid arthritis, however, citrullination is
a more generalized phenomenon - with increased citrulli-
nation seen in the synovial fluid of inflamed joints
affected by spondyloarthropathy [4] as well as in inflamed
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muscle in myositis and [8] myelin basic protein in multi-
ple sclerosis [9].
The role of protein citrullination in rheumatoid arthri-
tis is enigmatic, although most evidence supports a
pathologic role. Citrullinated fibrinogen [10] and citrulli-
nated collagen type II [11] are more immunogenic and
arthritogenic in mouse models of arthritis, and citrulli-
nated fibrinogen activates macrophages more than
unmodified fibrinogen [12]. Further, treatment with Cl-
amidine, a pan-PAD inhibitor, improves collagen-
induced arthritis [13]. In contrast, citrullinated CXCL10,
CXCL11 [14], IL-8 [15], and CXCL12 [16] lose inflam-
matory function, but these proteins have not been
shown to be citrullinated in rheumatoid arthritis.
Some proteins that have been shown to be citrulli-
nated in rheumatoid arthritis include type II collagen,
vimentin, fibrinogen, and fibronectin [17,18]. Fibronectin
is interesting because it modulates numerous cellular
behaviors including migration, adhesion, invasion, and
survival. More specific to rheumatoid arthritis, fibronec-
tin is deposited on the surface of articular cartilage in
the rheumatoid joint [19] and increases the ability of
synovial fibroblasts to adhere to cartilage [20].
Synovial fibroblasts are cells that normally line the joint.
These fibroblasts play a significant role in rheumatoid
arthritis by increasing in number as part of a pannus and
by degrading cartilage and bone using matrix metallopro-
teases and invasive structures called invadopodia [21].
Synovial fibroblasts also can migrate in the bloodstream to
invade distant cartilage in mouse models [22], which may
explain how multiple joints are involved in rheumatoid
arthritis.
Fibronectin plays an important role in synovial fibroblast
behavior. Synovial fibroblasts express the integrins a5b1
and avb3, which are important for fibronectin binding
[23], and fibronectin is present throughout the pannus
[24]. Further, fibronectin mediates synovial fibroblast
adhesion to cartilage, stabilizes invadopodia [25], and
modulates matrix metalloprotease production [26].
Despite the importance of fibronectin in synovial fibro-
blast and arthritis pathology, almost nothing is known
about the function of citrullinated fibronectin. We know
only that there is increased affinity of citrullinated fibro-
nectin for vascular endothelial growth factor but decreased
affinity for b1 integrin and decreased ability of citrullinated
fibronectin to cause apoptosis of HL-60 cells [27].
Given the presence of citrullinated fibronectin in rheu-
matoid arthritis, the paucity of information about citrulli-
nated fibronectin, and the importance of the interactions
of fibronectin and synovial fibroblasts in rheumatoid arthri-
tis, we decided to investigate how citrullinated fibronectin
modulates synovial fibroblast behavior. We report in this
paper that citrullinated fibronectin leads to impaired
adhesion, spreading, migration, and integrin-mediated




De-identified synovial fluid samples from patients given a
diagnosis of rheumatoid arthritis by a rheumatologist
were provided by physicians not associated with this
research. Joint aspiration was part of routine care for the
patients. This research does not meet the definition of
human subjects research or require informed consent as
confirmed by the University of Wisconsin Institutional
Review Board.
Animals
TNF transgenic mice (line 3647) [28] were generously
provided by Dr Edward Schwarz and permission for their
use was generously provided by Dr George Kollias at the
Alexander Fleming Biomedical Sciences Research Centre.
TNF transgenic and C57BL/6 mice were cared for and
euthanized in a manner approved by the University of
Wisconsin Animal Care and Use Committee.
Synovial fibroblast cultures
Synovial fibroblast cultures were prepared from mouse
ankle joints using standard methods and from human
synovial fluid according to published protocols [29].
Briefly, mice were euthanized and ankle joints were
removed, minced, and incubated for 2 to 3 hours in a col-
lagenase solution at 37°C to release cells for plating in a
media of DMEM with 10% fetal bovine serum (FBS),
L-glutamine, nonessential amino acids, essential amino
acids, penicillin, streptomycin, and b-mercaptoethanol.
Human synovial fluid was centrifuged for 10 to 20 min-
utes and the cell pellet resuspended in the above media.
Sometimes trypsin was used to help disrupt cell clumps
in synovial fluid. All synovial fibroblasts were used
between passages 5 and 9. Before use, mouse synovial
fibroblasts were confirmed to express vascular cell adhe-
sion molecule-1 and not F4/80 or CD45 and human
synovial fibroblasts were confirmed to express CD90 and
not CD68 (data not shown). Cells were serum starved
overnight before all experiments in media identical to
above, but with only 0.1% FBS.
Citrullination in vitro
Fibronectin was purified from human plasma by affinity
chromatography as described previously [30]. This fibro-
nectin was citrullinated as previously described by incu-
bating 500 mg overnight at 37°C in a buffer of 100 mM
Tris, pH 7.4, and 5 mM CaCl2 with 5 units PAD isolated
from rabbit skeletal muscle (Sigma-Aldrich St. Louis,
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MO, USA) in a total of 1 ml [27]. As controls, fibronectin
was incubated in buffer alone or in buffer with PAD that
had been heat-inactivated at 95°C for 20 minutes. Heat-
inactivation of citrullinating capability was confirmed by a
colorimetric assay using published protocols [31]. Fibro-
nectin samples were subjected to SDS-PAGE followed by
staining with Coomassie Blue using standard methods to
evaluate mobility shift.
Fibronectin coating
Nontissue culture-treated 35 mm petri dishes (BD Bios-
ciences San Jose, CA USA) were coated by incubation at
37°C for 1.5 hours with 10 μg/ml fibronectin, citrullinated
fibronectin, or fibronectin that had been incubated with
heat-inactivated PAD. Dishes were washed with PBS,
blocked with 2% BSA, and washed again with PBS. Equiva-
lent coating was assessed by coating and washing plastic
dishes, and then incubating with BCA reagent (Thermo
Scientific Rockford, IL USA) according to the manufac-
turer’s instructions using a protein standard.
Cell spreading and attachment assay
Synovial fibroblasts were incubated on plates coated with
BSA, fibronectin, citrullinated fibronectin, or fibronectin
exposed to heat-inactivated PAD. A 10× field that con-
tained an average of 30 cells was chosen and time-lapse
microscopy was used to image the field every minute.
Every 5 minutes the percentage of cells that were no
longer floating and had begun to spread and attach was
assessed. Cells that were touching other cells or were not
completely in the field of view were excluded.
Migration/haptotaxis assay
Murine synovial fibroblasts (2 × 104) in 0.1% FBS media
were placed in the upper chamber of a transwell. The
lower chamber contained 0.1% FBS media with no addi-
tive, 10 μg/ml fibronectin, 10 μg/ml citrullinated fibronec-
tin, or 10 μg/ml fibronectin that had been incubated with
heat-inactivated PAD. After 6 hours, nonmigrated cells
were removed with a cotton swab and the membranes
were fixed in methanol and stained with H & E.
Western blots
For western blot of fibronectin, the fibronectin samples
were run by SDS-PAGE under nonreducing conditions,
transferred to nitrocellulose and blotted with the anti-
fibronectin antibodies 4D1 and 5C3 [32]. For western
blots of cell lysates, adherent cells were scraped into lysis
buffer (5 mM Tris, pH 7.4; 500 mM NaCl; 0.1% SDS; 0.5%
sodium deoxycholate; 0.5 mM MgCl2) on ice containing
2 μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin,
0.2 mM phenylmethylsulfonyl fluoride and 1 mM sodium
vanadate. For the BSA control, floating cells were used
because the cells do not adhere. Equivalent amounts of
cell lysates were subjected to SDS-PAGE and transferred
to nitrocellulose for western blotting using anti-focal
adhesion kinase (anti-FAK, clone 77; BD Biosciences),
anti-paxillin (clone 349; BD Biosciences), anti-phospho-
Tyr-397 FAK (polyclonal; Life Technologies, Grand
Island, NY, USA), and anti-phospho-Tyr-118 paxillin
(polyclonal; Life Technologies) followed by imaging with
an Odyssey infrared imaging system (LI-COR Biosciences,
Lincoln, Nebraska USA).
Gelatin degradation assay
Gelatin coverslips were prepared as published previously
[33]. Briefly, coverslips were treated with 50 μg/ml poly-L-
lysine, then 0.5% glutaraldehyde, then 0.2% Oregon green
gelatin, and then 5 mg/ml NaBH4 with PBS washing steps
between each treatment. Coverslips were then coated with
10 μg/ml fibronectin or citrullinated fibronectin as
described above. About 10,000 synovial fibroblasts from
TNF transgenic mice were plated for 4 hours on the cov-
erslips before fixation with 3% formaldehyde, quenching
with glycine, permeabilization with 0.2% Triton-X 100,
blocking with goat serum and incubating with mouse anti-
cortactin (clone 4F11; Millipore Billerica, MA USA) fol-
lowed by washing and incubating with goat anti-mouse
rhodamine red. Coverslips were mounted and viewed at
60× magnification.
Data analysis
Prism software was used for statistical analysis (Orange
County, CA USA). Data were analyzed by one-way analysis
of variance or unpaired t test as appropriate.
Results
To assess the effect of citrullinated fibronectin on synovial
fibroblasts, we first prepared citrullinated fibronectin. We
used the same method of in vitro citrullination as Chang
and colleagues, who evaluated the binding of citrullinated
fibronectin to b1 integrin [27]. The citrullinated fibrinogen
that caused increased macrophage activation, immuno-
genicity, and arthritogenicity was prepared using similar
methods and reagents [10,12]. In brief, fibronectin was
incubated with buffer containing PAD or, as a control,
buffer alone. As an additional control, we used fibronectin
exposed to PAD that was heat-inactivated at 95°C. Heat-
inactivated PAD does not have any detectable citrullinat-
ing activity and appears to stay in solution (data not
shown).
Since the anti-modified citrulline antibody used by
numerous other groups has been unavailable for years, we
took a different approach to assess citrullination. Citrulli-
nated fibrinogen has been shown to have delayed migration
by SDS-PAGE [10], so we assessed citrullination of fibro-
nectin by mobility shift. As shown in Figure 1A, citrulli-
nated fibronectin migrates more slowly by SDS-PAGE. We
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also confirmed the loss of arginine number 107 by western
blot. To do so, we used two different antibodies against
fibronectin; 4D1 recognizes an epitope in which arginine
107 is critical, and 5C3 recognizes an epitope in which no
arginine has been shown to be critical [32]. Both antibo-
dies recognize conformationally determined epitopes that
are lost upon reduction [32], requiring us to run our gel
under nonreducing conditions. As shown in Figure 1B,
both 5C3 and 4D1 recognize the untreated fibronectin
sample, but only 5C3 binds to the citrullinated fibronectin.
The inability of 4D1 to bind to the citrullinated fibronectin
suggests that there has been a loss of arginine at position
107. Of note, multiple bands of untreated fibronectin are
detected by western blot, but only one citrullinated fibro-
nectin band is seen. Fibronectin self-aggregates in solution
[34,35], and thus the multiple bands in the untreated
fibronectin lane probably represent monomers and differ-
ent size multimers. Only a single monomer band of citrul-
linated fibronectin is detected, probably because the loss
of charge via citrullination alters the ability of fibronectin
molecules to aggregate. As additional evidence of citrulli-
nation, we found that citrullinated fibronectin was less
degraded when treated with trypsin, which cleaves at
lysine and arginine, the latter of which is converted to
citrulline by PAD (data not shown).
Since citrullinated fibronectin has a reduced charge, we
tested whether it coated plastic equally to untreated fibro-
nectin. Plastic wells were incubated with PBS, fibronectin,
or citrullinated fibronectin and washed with PBS. The
amount of coated protein on the plastic was quantified
and found to be equal for untreated and citrullinated
fibronectin (Figure 1C).
To assess the ability of synovial fibroblasts to attach to
citrullinated fibronectin, murine synovial fibroblasts were
plated on plastic dishes coated with fibronectin, citrulli-
nated fibronectin, or fibronectin incubated with heat-inac-
tivated PAD. A 10× field was imaged using time-lapse
microscopy. The percentage of cells that were no longer
floating and had attached to the plate in the 10× field was
quantified every 5 minutes. As shown in Figure 2A, mur-
ine synovial fibroblasts had delayed attachment on citrulli-
nated fibronectin compared with control fibronectin and
fibronectin exposed to heat-inactivated PAD. Furthermore,
cells were less spread on citrullinated fibronectin at the
end of the 2-hour experiment (Figure 2B).
Fibronectin also mediates cell migration. To determine
whether citrullination of fibronectin modulates synovial
fibroblast migration, haptotactic transwell assays were
performed toward a gradient of fibronectin on the lower
surface of the membrane. The cells were allowed to
migrate for 6 hours toward media containing fibronectin,
citrullinated fibronectin, or fibronectin that had been
incubated with heat-inactivated PAD. Because serum has
fibronectin, which coats the transwells during the course
of the experiment, it cannot be used as an attractant. As
shown in Figure 3, synovial fibroblasts have impaired
migration toward citrullinated fibronectin compared with
untreated fibronectin or fibronectin treated with heat-
inactivated PAD. We also assessed random migration of


























Figure 1 In vitro citrullinated fibronectin has delayed migration by SDS-PAGE, altered antigenicity, but coats plastic normally. (A)
Fibronectin incubated in buffer (FN), fibronectin incubated in buffer with peptidyl arginine deiminase (FNC), and fibronectin incubated in buffer
with heat-inactivated peptidyl arginine deiminase (FNHI) were subjected to SDS-PAGE under reducing conditions followed by Coomassie Blue
staining. Gel is representative of three experiments. Thick band at the bottom left of the gel shows the four indicated size markers combined in
this 6% acrylamide gel. L, protein standard ladder. (B) FN and FNC were subjected to SDS-PAGE under nonreducing conditions followed by
western blotting with the anti-fibronectin antibodies 5C3 or 4D1 (4D1 requires Arg107 for binding.). Blots are representative of three
experiments. (C) Plastic wells were incubated with PBS, FN, or FNC followed by washing with PBS. Adhered protein was quantified using BCA
reagent. Data shown are the average and standard error of 10 replicates from two independent experiments.
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using time-lapse microscopy. While there is a trend
towards reduced migration on citrullinated fibronectin
compared with untreated fibronectin, the cells in both
treatment groups randomly migrate very little and the
decrease is not statistically significant (data not shown).
Taken together, these findings suggest that citrullination
of fibronectin impairs both synovial fibroblast attachment
and migration.
Fibronectin signals through integrins to activate a cas-
cade of proteins leading to cytoskeletal changes necessary
for cell adhesion and migration. Two proteins that
function early in integrin-mediated signaling and become
phosphorylated by integrin ligation are FAK and paxillin.
Given our observations of poor attachment and migra-
tion on citrullinated fibronectin, and the fact that b1
integrin has decreased affinity for citrullinated fibronectin
[27], we wanted to assess phosphorylation of FAK and
paxillin in response to citrullinated fibronectin. We pla-
ted synovial fibroblasts on dishes coated with BSA, fibro-
nectin, citrullinated fibronectin, or fibronectin that had
been incubated with heat-inactivated PAD. Cell lysates
were obtained after 3 hours and were subjected to wes-
tern blotting for total FAK, phospho-FAK, total paxillin,
and phospho-paxillin. Blots were analyzed by densitome-
try and the amount of phosphorylated protein was nor-
malized to the amount of total protein. As shown in
Figure 4, synovial fibroblasts have reduced phosphoryla-
tion of both FAK and paxillin on citrullinated fibronectin,
suggesting that citrullination of fibronectin impairs integ-
rin-mediated signaling.
We next wanted to determine whether arthritic syno-
vial fibroblasts also had attachment and spreading
defects on citrullinated fibronectin. Therefore we
assessed attachment of synovial fibroblasts from mice
with chronic arthritis due to overexpression of TNFa
[28]. Using identical techniques as with the normal mur-
ine synovial fibroblasts, we found that murine arthritic
synovial fibroblasts have a similar delay in attachment
on citrullinated fibronectin compared with untreated
fibronectin (Figure 5A). Spreading was also impaired on































Figure 2 Murine synovial fibroblasts have impaired attachment and spreading on citrullinated fibronectin. (A) Murine synovial
fibroblasts were plated on dishes coated with fibronectin (FN), citrullinated fibronectin (FNC), or fibronectin incubated with heat-inactivated
peptidyl arginine deiminase (FNHI) and were imaged using time-lapse microscopy at 10× magnification. The percentage of cells attached in a
10× field was determined every 5 minutes. Graph depicts average and standard error at each time point (n = 4 experiments). *P < 0.05. (B)






























Figure 3 Murine synovial fibroblasts have impaired migration
towards citrullinated fibronectin. Synovial fibroblasts were
allowed to migrate for 6 hours towards no additive (Null),
fibronectin (FN), citrullinated fibronectin (FNC), or fibronectin
incubated with heat-inactivated peptidyl arginine deiminase (FNHI).
Graph shows the average number of migrated cells per 10× field
with standard error for five experiments. Ten 10× fields were
counted for each sample. *P < 0.05, ***P < 0.005.
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Even more physiologically relevant would be an abnorm-
ality in adhesion seen with rheumatoid synovial fibroblasts.
We therefore isolated synovial fibroblasts from patients
with rheumatoid arthritis and repeated our attachment
studies. As shown in Figure 5B, adhesion was delayed on
citrullinated versus untreated fibronectin for rheumatoid
synovial fibroblasts. We also evaluated cell spreading 3
hours after plating cells on fibronectin and citrullinated
fibronectin. Rheumatoid synovial fibroblasts had impaired
cell spreading and the cells displayed an abnormal mor-
phology with extension of spindly processes on citrulli-
nated fibronectin (Figure 5C). For both murine and
human arthritic synovial fibroblasts, results on untreated
fibronectin were similar to fibronectin that had been incu-
bated with heat-inactivated PAD (data not shown).
One of the most harmful characteristics of synovial
fibroblasts is their invasive capability. Cellular invasion
requires cell adhesion, migration, and the formation of
invasive structures that focally degrade matrix. We were
able to show defects in adhesion and migration on citrul-
linated fibronectin (Figures 2, 3, and 5). We therefore
wanted to assess whether citrullinated fibronectin also
altered focal matrix degradation by arthritic synovial
fibroblasts. To this end, we plated arthritic synovial fibro-
blasts from mice that overexpress TNFa on coverslips
that had first been coated with fluorescent gelatin and
then with either fibronectin or citrullinated fibronectin.
After 4 hours, cells were fixed, permeabilized, and stained
for cortactin, a marker of invadopodia. As shown in Fig-
ure 5D, some cells are able to focally degrade gelatin on
either citrullinated or untreated fibronectin, although
they tend to move over the course of the experiment and
do not align perfectly with their areas of degradation.
The percentage of cells that degraded matrix was calcu-
lated and was the same for citrullinated versus untreated
fibronectin (Figure 5E). Similar results were seen for
rheumatoid synovial fibroblasts but a much larger per-
centage of cells were degrading gelatin on either sub-
strate, making it impossible to determine whether
citrullinated fibronectin increased degradation. Of note,
each degrading cell had a somewhat different pattern and
density of degradation, but there were no differences in
the degradation patterns on control versus citrullinated
fibronectin.
Discussion
In this article we provide the first report of how synovial
fibroblasts behave on citrullinated matrix, specifically
how they adhere, migrate, and invade in the presence of
citrullinated fibronectin. Understanding the interactions
between synovial fibroblasts and citrullinated fibronectin
is important for understanding the pathophysiology of
rheumatoid arthritis. Fibronectin mediates many synovial
fibroblast functions and is citrullinated in rheumatoid
arthritis. Moreover, synovial fibroblasts are part of the
destructive process of rheumatoid arthritis. However,
until this work, the role of citrullinated fibronectin in
synovial fibroblast behavior was unknown.
We have shown that synovial fibroblasts have impaired
adhesion (Figures 2 and 5) and migration (Figure 3) on
citrullinated fibronectin. Previous work has shown that
fibronectin enhances adhesion of synovial fibroblasts to
the rheumatoid joint, potentially leading to joint destruc-
tion. Further, migration of synovial fibroblasts in the
bloodstream may contribute to the spread of rheumatoid
arthritis. Given this information, one could hypothesize
that citrullination of fibronectin, as is seen in rheumatoid
arthritis, might be a mechanism to prevent synovial fibro-
blast adhesion and joint destruction as well as to inhibit
migration of synovial fibroblasts and arthritis spread.
Since citrullination occurs in joints affected by other














































Figure 4 Murine synovial fibroblasts have impaired integrin-mediated signaling on citrullinated fibronectin. Synovial fibroblasts were
allowed to adhere for 3 hours on plates coated with BSA as a negative control, fibronectin (FN), citrullinated fibronectin (FNC), or fibronectin
incubated with heat-inactivated peptidyl arginine deiminase (FNHI). Cell lysates were subjected to SDS-PAGE followed by western blotting for
total focal adhesion kinase (FAK), FAK phosphorylated at Y397, total paxillin, and paxillin phosphorylated at Y118. (A) Blots shown are
representative of three experiments. (B) Western blots were quantified by densitometry. The amount of phosphorylated protein was normalized
to total protein and this value was normalized to the overall intensity of the blots. The average and standard error are shown for three
experiments. *P < 0.05, **P < 0.01, ***P < 0.005.
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mechanism to limit joint destruction in the setting of
inflammation. In this scenario, citrullination has protec-
tive functions, which would be a novel role for citrullina-
tion since, to date, most studies of proteins citrullinated
in rheumatoid arthritis have suggested a harmful role.
However, the alternative might also be true with poor
adhesion of synovial fibroblasts leading to more metasta-
sis of these cells and the spread of arthritis.
Directly investigating the role of citrullinated fibronec-
tin in vivo is difficult since overexpressing or knocking
out PAD2 and/or PAD4 would alter citrullination of












































































Figure 5 Arthritic synovial fibroblasts have impaired adhesion and spreading on citrullinated fibronectin, but normal gelatin
degradation. (A) Synovial fibroblasts derived from arthritic mice were plated on fibronectin (FN) or citrullinated fibronectin (FNC) and were
imaged using time-lapse microscopy at 10× magnification. The percentage of cells attached in a 10× field was determined every 5 minutes.
Graph depicts average and standard error at each time point (n = 3 experiments). (B) Synovial fibroblasts derived from the synovial fluid of
patients with rheumatoid arthritis were plated on FN or FNC and imaged using time-lapse microscopy as in (A). Graph depicts average and
standard error at each time point (n = 3 experiments). (C) Representative images of rheumatoid synovial fibroblasts plated on FN or FNC for
3 hours. Magnification is 20×. Bar = 100 μm. (D) Synovial fibroblasts from TNFa-overexpressing mice were plated on coverslips coated with
fluorescent gelatin and either FN or FNC. After 4 hours, coverslips were fixed and stained for cortactin (a marker of invadopodia). Representative
images of degrading cells are shown at 60× with the same field shown for both cortactin and gelatin. Bar = 20 μm. (E) Graph depicts the
percentage of cells that showed areas of gelatin degradation. For each experiment, 100 cells were evaluated per sample (n = 3 experiments).
*P < 0.05, **P < 0.01, ***P < 0.005.
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However, such studies are warranted to address the role of
citrullination in general since citrullination occurs in rheu-
matoid arthritis and since ACPAs are pathologic. Further,
chemicals such as Cl-amidine are being studied for treat-
ing arthritis and it will be important to understand all the
potential effects of this chemical and similar others.
Finally, citrullination occurs in multiple inflammatory con-
ditions [8,9], in the lungs of smokers [36], and in different
cancers [37], and there may be a common role for citrulli-
nation in all of these processes that is important to under-
stand. This paper is one of the first steps in understanding
the role of citrullination since fibronectin plays a critical
role in the behavior of cells in inflammation and cancer.
We assessed whether citrullinated fibronectin would
alter matrix degradation, a pathologic function of syno-
vial fibroblasts in rheumatoid arthritis. We found no dif-
ference in the number of degrading cells in the presence
of citrullinated versus untreated fibronectin. This was
surprising to us. We had predicted either an increase in
the number of degrading cells given the increased arthri-
togenicity of citrullinated collagen and fibrinogen, or a
decrease in degrading cells due to the importance of
fibronectin in matrix metalloprotease production and
invadopodia stability. We performed additional experi-
ments that showed no alteration in invasion through
Matrigel invasion chambers incubated with PAD com-
pared with untreated chambers (data not shown), but in
those experiments multiple matrix proteins were prob-
ably citrullinated and the specific role of citrullinated
fibronectin could not be addressed. However, those
results are in agreement with the findings of our focal
degradation experiments on fibronectin. Citrullination of
fibronectin therefore appears to affect some synovial
fibroblast behaviors but not all.
We also addressed the mechanism of impaired synovial
fibroblast adhesion and migration on citrullinated fibronec-
tin and found reduced phosphorylation of FAK and paxil-
lin. This observation, in combination with the known
decreased affinity of citrullinated fibronectin for b1 integrin
[27], suggests that the impaired adhesion and migration is
due to decreased binding of citrullinated fibronectin to
integrins and subsequent decreased integrin-mediated
signaling.
We tried to assess whether the canonical cell-binding
RGD domain was involved with poor adhesion on citrulli-
nated fibronectin. In competition experiments using RGD
peptide to interfere with synovial fibroblast adhesion to
fibronectin, however, we found that even high concentra-
tions of RGD peptide did not significantly alter synovial
fibroblast attachment in our assay. We were therefore
unable to show lack of competition using a peptide with
arginine replaced by citrulline (data not shown). Another
domain known to mediate adhesion is the heparan sulfate
binding domain. The major heparin binding sequences
contain arginines [38], so this domain may be important
for synovial fibroblast adhesion to fibronectin and impaired
adhesion to citrullinated fibronectin. A general loss of ter-
tiary structure with citrullination, as has been shown for
other proteins [39], may also impair fibronectin’s function
and protein interactions and thus be responsible for altered
synovial fibroblast behavior on citrullinated fibronectin.
Altered tertiary structure or loss of arginines in portions of
fibronectin not yet recognized to be involved with synovial
fibroblast adhesion may be the most probable explanation
for the observed cellular defects on citrullinated fibronectin
since, to date, only five arginines in human fibronectin pur-
ified from the synovial fluid of two people with rheumatoid
arthritis have been identified as citrullinated [40], none of
which are in the RGD domain or the heparan sulfate bind-
ing domain.
One important caveat in interpreting our studies, how-
ever, is that the effects of in vitro citrullinated human
plasma fibronectin by PAD from rabbit skeletal muscle
on mouse and human synovial fibroblasts might be dif-
ferent from the effects of physiologic citrullination of
fibronectin on synovial fibroblasts in the inflamed human
joint. Nonetheless, the alterations of synovial fibroblast
behavior on citrullinated fibronectin that we report here
open the doors to future studies.
Conclusion
This is the first paper to show how citrullinated fibronec-
tin, which is present in rheumatoid arthritis, alters the
behavior of both normal and rheumatoid synovial fibro-
blasts. Given the pathologic role of ACPAs in rheumatoid
arthritis, the presence of citrullination in inflammation and
cancer, and the importance of communication between
cells and extracellular matrix proteins, the implications of
this work may be profound. However, further studies are
needed to address the role of citrullinated fibronectin and
other citrullinated extracellular matrix proteins in arthritis
and other diseases both in vitro and in vivo.
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